Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis.

about

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis.

Item

http://www.wikidata.org/entity/Q41472845

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Increased MAPK1/3 Phosphorylat ...... tspot Mutations and Prognosis.

@en

type

Item

label

Increased MAPK1/3 Phosphorylat ...... tspot Mutations and Prognosis.

@en

prefLabel

Increased MAPK1/3 Phosphorylat ...... tspot Mutations and Prognosis.

@en

P1476

Increased MAPK1/3 Phosphorylat ...... tspot Mutations and Prognosis.

@en

P2093

A Mieke Timmermans

http://www.w3.org/2001/XMLSchema#string

Diana Ramirez-Ardila

http://www.w3.org/2001/XMLSchema#string

Els M J J Berns

http://www.w3.org/2001/XMLSchema#string

Jean A Helmijr

http://www.w3.org/2001/XMLSchema#string

John W M Martens

http://www.w3.org/2001/XMLSchema#string

Maurice P H M Jansen

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer.

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.

PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab

SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy

Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.

P304

854-866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRANON.2017.08.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28886403

http://www.w3.org/2001/XMLSchema#string

P932

5591392

http://www.w3.org/2001/XMLSchema#string